Most giant pheochromocytomas do not present with classic symptoms, as documented by published case reports. Given this, clinicians have to consider a wide differential diagnosis for any retroperitoneal mass and perform screening tests to rule out a pheochromocytoma. We describe the largest pheochromocytoma reported in Canada, where the patient presented with a palpable abdominal mass and dyspnea. The 19 × 18 × 12-cm right retroperitoneal mass was biochemically active and was radiologically and pathologically consistent with a giant pheochromocytoma. We present this case and review the relevant current literature.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039607 | PMC |
| http://dx.doi.org/10.5489/cuaj.1719 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Paraganglioma and phaeochromocytoma in adult Fontan patients.
J Med Imaging Radiat Oncol
February 2025
Department of Medical Imaging, University Health Network, JDMI, Toronto, Ontario, Canada.
Introduction: The purpose of this study was to address the gap in knowledge in the incidence, presentation and imaging features of PPGL in Fontan patients. It has been hypothesised in the literature that Fontan circulation patients have an increased incidence of these tumours. This study is the largest cohort of adult Fontan patients in North America.
View Article and Find Full Text PDFA Malignant Duo: Mixed Medullary and Follicular Variant Papillary Thyroid Cancer.
Cureus
August 2024
Endocrinology, Hospital Corporation of America (HCA) Florida Osceola Hospital, Kissimmee, USA.
Medullary thyroid cancer (MTC) is a relatively rare thyroid malignancy, constituting a small percentage of all thyroid cancer cases. Even more rare is the occurrence of mixed MTC and papillary thyroid cancer (PTC), found in a very small fraction of MTC cases. These cancers originate from different cell types with distinct developmental origins.
View Article and Find Full Text PDFMAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma.
Best Pract Res Clin Endocrinol Metab
December 2024
Hereditary Endocrine Cancer Group; Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain. Electronic address:
Pheochromocytomas and paragangliomas are rare neuroendocrine tumours. Around 20-25 % of patients develop metastases, for which there is an urgent need of prognostic markers and therapeutic stratification strategies. The presence of a MAML3-fusion is associated with increased metastatic risk, but neither the processes underlying disease progression, nor targetable vulnerabilities have been addressed.
View Article and Find Full Text PDFRobot-assisted laparoscopic adrenalectomy: Extended application in children.
Eur J Surg Oncol
December 2024
Department of Pediatric Surgery and Urology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; Université de Paris Cité, Paris, France. Electronic address: https://twitter.com/hopital_necker.
Background: Minimally invasive surgery for paediatric adrenal tumours has evolved, but robot-assisted laparoscopic adrenalectomy (RALA) in children remains poorly studied. The current prospective study aims to demonstrate the safety and efficacy of RALA in treating children with adrenal tumours.
Methods: A prospective institutional analysis of children presenting with neuroblastic and endocrine tumours treated with RALA was undertaken over a six year-period.
Genetic background and intraoperative haemodynamic instability in patients with pheochromocytoma and paraganglioma: a multicentre retrospective study.
Int J Surg
January 2025
Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
Article Synopsis
- This study examined the relationship between genetic variants and intraoperative haemodynamic instability (IHI) in patients undergoing surgery for pheochromocytomas and paragangliomas (PPGLs).
- Out of 671 patients analyzed, 61.8% experienced IHI, with a significant correlation found between IHI and specific genetic mutations, particularly those in the HRAS gene.
- Other factors influencing IHI included age at tumor diagnosis, presence of catecholamine-associated symptoms, and tumor size, with the genetic background being the most influential contributor.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!